Blue Cross Blue Shield of Mississippi
site map

About Us   Careers    Site Map

  • Be Healthy
  • I'm a Member
  • I'm a Provider
  • I'm an Employer
  • Find Coverage

I'm a provider

You will be redirected to myBlue. Would you like to continue?

please waitPlease wait while you are redirected.

myBlue login
 Username:
 Password:
  • Forgot Password »
  • More Information »

be RxSmart

Medical & Coding Policies

Provider Network Application

Out-of-State & Non-Network

Contact Us

Provider Links

Healthy You! Provider Information »

E-solutions & Online Tools »

Provider Forms »

Articles & Updates »

National Provider Identifier »

Good Health Club for Kids »

Medical Policy Search
Printer Friendly Version Lung and Lobar Lung Transplant

Lung and Lobar Lung Transplant

 

DESCRIPTION

A lung transplant refers to single-lung or double-lung replacement. In a single-lung transplant, only one lung from a cadaver donor is provided to the recipient. In a double-lung transplant, the recipient's lungs are removed and replaced by the donor's lungs.

In a lobar transplant, a lobe of the donor's lung is excised, sized appropriately for the recipient's thoracic dimensions and is transplanted. Donors for lobar transplant have been primarily living related donors, with one lobe obtained from each of two donors (e.g. mother and father). In situations where a bilateral transplant is required, there are also cases of cadaver lobe transplants.

 

POLICY

No benefits will be provided for a covered transplant procedure or a transplant evaluation unless the Member receives prior authorization through case management from Blue Cross & Blue Shield of Mississippi.

Lung transplantation is medically necessary for carefully selected patients with irreversible, progressively disabling, end-stage pulmonary disease including, but not limited to one of the conditions listed below.

A lobar lung transplant is considered medically necessary for carefully selected patients with end-stage pulmonary disease including, but not limited to one of the conditions listed below:

  • Bilateral bronchiectasis
  • Alpha-1 antitrypsin deficiency
  • Primary pulmonary hypertension
  • Pulmonary fibrosis
  • Cystic fibrosis (both lungs to be transplanted)
  • Bronchopulmonary dysplasia
  • Idiopathic pulmonary fibrosis
  • Sarcoidosi
  • Scleroderma
  • Lymphangiomyomatosis-Lung
  • Emphysema
  • Eosinophilic granuloma
  • Bronchiolitis obliterans
  • Recurrent pulmonary embolism
  • Pulmonary hypertension due to cardiac disease
  • Chronic obstructive pulmonary disease
  • Eisenmenger's syndrome
  • Interstitial pulmonary fibrosis
  • Emphysematous bleb

 

POLICY EXCEPTIONS

For Federal Employee Program (FEP) subscribers only, lung and lobar lung transplant may be considered medically necessary. (See FEP policy)

For State and School Employee subscribers, all transplants must be certified as medically necessary by the Plan’s Utilization Review Vendor. No benefits will be provided for any transplant procedure unless prior approval for the transplant is obtained. 

 

POLICY GUIDELINES

Potential contraindications subject to the judgment of the transplant center:
  1. Known current malignancy, including metastatic cancer
  2. Recent malignancy with high risk of recurrence
  3. Untreated systemic infection making immunosuppression unsafe, including chronic infection
  4. Other irreversible end-stage disease not attributed to lung disease
  5. History of cancer with a moderate risk of recurrence
  6. Systemic disease that could be exacerbated by immunosuppression
  7. Psychosocial conditions or chemical dependency affecting ability to adhere to therapy
  8. Coronary artery disease (CAD) not amenable to percutaneous intervention or bypass grafting, or associated with significant impairment of left ventricular function; or
  9. Colonization with highly resistant or highly virulent bacteria, fungi, or mycobacteria.

*Some patients may be candidates for combined heart-lung transplantation

Patients must meet UNOS guidelines for lung allocation score (LAS) greater than zero.

Lung Specific
Bilateral lung transplantation is typically required when chronic lung infection disease is present, i.e., associated with cystic fibrosis and bronchiectasis. Some, but not all, cases of pulmonary hypertension will require bilateral lung transplantation.

Bronchiolitis obliterans is associated with chronic lung transplant rejection, and thus may be the etiology of a request for lung retransplantation.

The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language.

 

POLICY HISTORY

8/1998: Approved by Medical Policy Advisory Committee (MPAC)

3/5/2002: Policy exception deleted

5/1/2002: Type of Service and Place of Service deleted

8/20/2003: ICD-9 procedure code range 33.50-33.52 listed separately, ICD-9 diagnosis code range 011.0-011.2, 011.4, 011.9, 277.00-277.01, 402.00-402.91, 415.11-415.19, 416.0, 416.8, 416.9, 491.20-491.21, 500-505 listed separately

6/23/2004: Policy reviewed, Sources updated, Policy exception added

07/21/2005: Policy reviewed by MPAC, "HIV positivity is not an absolute contraindication to transplant. Each individual transplant certer will determine patient selection criteria for HIV positive patients"

10/17/2005: Code Reference table updated: CPT codes 32855, 32856 added; ICD-9 procedure code 00.91, 00.92, 00.93 added; HCPCS codes S2060, S2061 S2152 added; diagnosis code 518.3 added

3/14/2006:  Coding updated.  CPT4 2006 revisions added to policy.

3/23/2006:  Coding updated.  CPT4 2006 revisions added to policy.

9/20/2007: Code Reference section updated. ICD-9 2007 revisions added to policy

4/23/2009: Policy reviewed, no changes

9/28/2009:  Code reference section updated. New ICD-9 diagnosis code 416.2 added to covered table. ICD-9 procedure codes 32.3, 32.4, 32.5 deleted codes as of  9-30-2007 deleted from the covered table.

02/23/2011: Policy statement and guidelines updated to include specific contraindications for lung transplant.

02/24/2012:  Deleted outdated references from the Sources section. Contraindications moved to the Policy Guidelines section, and the absolute and relative contraindications were combined. Deleted outdated references from the Sources section.

04/09/2013:  Policy reviewed. In the lobar policy statement, "children and adolescents" was changed to "carefully selected patients."

 

SOURCE(S)

Blue Cross Blue Shield Association policy # 7.03.07

 

CODE REFERENCE

This is not intended to be a comprehensive list of codes. Some covered procedure codes have multiple descriptions.

The code(s) listed below are ONLY covered if the procedure is performed according to the "Policy" section of this document.  

Covered Codes

Code Number

Description

CPT-4

00580

Anesthesia for heart transplant or heart/lung transplant (units: 20) (added 1-1-2006)

01990

Physiological support for harvesting of organ(s) from brain - dead patient (units: 7) (added 1-1-2006)

32480

Removal of lung; other than total pneumonectomy; single lobe (lobectomy) (added 10/17/2005)

32482

Removal of lung; other than total pneumonectomy; two lobes (bilobectomy) (added 10/17/2005)

32850

Donor pneumonectomy (including cold preservation), from cadaver donor (10/17/2005)

32851

Lung transplant, single; without cardiopulmonary bypass

32852

Lung transplant, single; with cardiopulmonary bypass

32853

Lung transplant, double (bilateral, sequential, or en bloc); without cardiopulmonary bypass

32854

Lung transplant, double (bilateral, sequential, or en bloc); with cardiopulmonary bypass (added 10/17/2005)

32855

Backbench standard preparation of cadaver donor lung allograft prior to transplantation, including dissection of allograft from surrounding soft tissues to prepare pulmonary venous/atrial cuff, pulmonary artery, and bronchus; unilateral (effective 1-1-2005) (added 10-17-2005)

32856

Backbench standard preparation of cadaver donor lung allograft prior to transplantation, including dissection of allograft from surrounding soft tissues to prepare pulmonary venous/atrial cuff, pulmonary artery, and bronchus; bilateral (effective 1-1-2005) (added 10-17-2005)

ICD-9 Procedure

00.91

Transplant from live related donor (code also organ transplant procedure) (effective 10/1/2004) (added 10/17/2005)

00.92

Transplant from live non-related donor (code also organ transplant procedure) (effective 10/1/2004) (added 10/17/2005)

00.93

Transplant from cadaver (code also organ transplant procedure) (effective 10/1/2004) (added 10/17/2005)

32.30

Thoracoscopic segmental resection of lung (new 10-1-2007)

32.39

Other and unspecified segmental resection of lung (new 10-1-2007) 

32.41

Thoracoscopic lobectomy of lung (new 10-1-2007)

32.49

Other lobectomy of lung (new 10-1-2007)

32.50

Thoracoscopic pneumonectomy (new 10-1-2007)

32.59

Other and unspecified pneumonectomy (new 10-1-2007)

33.50 

Lung transplantation, NOS

33.51 

Unilateral lung transplantation

33.52 

Bilateral lung transplantation

39.61

Cardiopulmonary bypass

ICD-9 Diagnosis

011.00,  011.01, 011.02, 011.03, 011.04,  011.05, 011.06, 011.10, 011.11, 011.12, 011.13, 011.14, 011.15, 011.16, 011.20, 011.21, 011.22, 011.23, 011.24, 011.25, 011.26

Tuberculosis of lung code range

011.40, 011.41, 011.42, 011.43, 011.44, 011.45, 011.46 

Tuberculous fibrosis of lung code range

011.90, 011.91,  011.92, 011.93, 011.94, 011.95, 011.96

Unspecified pulmonary tuberculosis code range

135

Sarcoidosis; lung involvement in other diseases classified elsewhere

235.7

Lymphangiomyomatosis lung

277.00, 277.01

Cystic fibrosis code range

277.6

Alpha-1 antitrypsin deficiency

277.89

Eosinophilic granuloma

402.00, 402.01

Malignant hypertensive heart disease code range

402.10, 402.11

Benign hypertensive heart disease code range

402.90, 402.91

Unspecified hypertensive heart disease code range

415.11

Iatrogenic pulmonary embolism and infarction

415.19 

Other pulmonary embolism and infarction

415.2

Septic pulmonary embolism (new 10-1-2007)

416.0 

Primary pulmonary hypertension

416.2

Chronic pulmonary embolism (new 10-1-2009)

416.8 

Other chronic pulmonary heart diseases

416.9 

Unspecified chronic pulmonary heart disease

491.20, 491.21

Obstructive chronic bronchitis code range

491.8

Bronchiolitis obliterans

492.0

Emphysematous bleb

492.8

Emphysema

494.0, 494.1

Bronchiectasis code range

496

Chronic obstructive pulmonary disease

500 

Coal workers' pneumoconiosis

501 

Asbestosis

502 

Pneumoconiosis due to other silica or silicates

503 

Pneumoconiosis due to other inorganic dust

504 

Pneumonopathy due to inhalation of other dust

505 

Unspecified pneumoconiosis

506.4

Pulmonary fibrosis due to fumes and vapors

508.1

Fibrosis of the lungs following radiation

515

Pulmonary fibrosis, post-inflammatory

516.3

Idiopathic pulmonary fibrosis

517.8

Lung involvement in other diseases classified elsewhere

518.1

Interstitial Emphysema

518.2

Compensatory Emphysema

518.3

Pulmonary eosinophilia (added 10/17/2005)

710.1

Scleroderma

745.4

Eisenmenger's syndrome

748.61

Congenital bronchiectasis

770.7

Bronchopulmonary dysplasia

HCPCS

S2060

Lobar lung transplantation (added 10/17/2005)

S2061

Donor lobectomy (lung) for transplantation, living donor (added 10/17/2005)

S2152

Solid organ(s), complete or segmental, single organ or combination of organs; deceased or living donor(s), procurements, transplantation, and related complications including:  drugs; supplies; hospitalization with outpatient follow-up; medical/surgical, diagnostic, emergency, and rehabilitative services; and the number of days of pre-and post-transplant care in the global definition (effective 4/1/2004) (added 10/172005)

 

Top




Copyright © 2007-2013, Blue Cross & Blue Shield of Mississippi, A Mutual Insurance Company. All Rights Reserved.
An independent licensee of the Blue Cross and Blue Shield Association.

About Us  ·   Careers   ·   Terms of Use  ·   Privacy Practices  ·   Accreditation  ·   Site Map